DOWDEN NATHAN J (Chief Operating Officer) received a stock award from ENTRADA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/3/2026ACC: 0001873392-26-000001
Officer· Chief Operating Officer
Since Oct 2021
+117.74K
Net shares
Net buyer
$249.2K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
139K acquired · 21.26K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+55.80K
Price / share
—
Trade value
—
% of position
31.2%
3/1/2026
179.06K→234.86K
Common Stock
Direct
Shares
−7.22K
Price / share
$11.66
Trade value
$84.21K
% of position
3.1%
3/2/2026
234.86K→227.64K
Common Stock
Direct
Shares
−14.04K
Price / share
$11.76
Trade value
$165.04K
% of position
6.2%
3/3/2026
227.64K→213.60K
Total
Net shares
+34.54K
Net value
-$249.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2026 | A · Award | +55.80K | — | — | 31.2% | 179.06K | 234.86K |
| Common Stock Direct | 3/2/2026 | F · Tax Withholding | −7.22K | $11.66 | $84.21K | 3.1% | 234.86K | 227.64K |
| Common Stock Direct | 3/3/2026 | F · Tax Withholding | −14.04K | $11.76 | $165.04K | 6.2% | 227.64K | 213.60K |
| Total | +34.54K | -$249.24K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
83.20K shares
Shares
+83.20K
Strike price
11.93
Held after
83.20K
Exercisable
—
3/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock83.20K shares | 3/1/2026 | A · Award | +83.20K | 11.93 | — | 83.20K |